Medicare Enrolled

Dr. Malini Pasricha, MD

Retina Specialist (Ophthalmology) Physician · San Francisco, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1445 BUSH ST, San Francisco, CA 94109
4159724600
In practice since 2017 (9 years)
NPI: 1215469606 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pasricha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pasricha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pasricha

Dr. Malini Pasricha is a retina specialist physician in San Francisco, CA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Pasricha performed 2,928 Medicare services across 889 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pasricha received a total of $12,732 from 15 pharmaceutical and/or device companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pasricha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ 2,928 Medicare services $12,732 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,928
Medicare services
Bottom 39% in CA for retina specialist (ophthalmology) physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
889
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~325 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
 1,740 $29 $110
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
 404 $39 $200
Aflibercept eye injection (Eylea) 266 $683 $4,500
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
 169 $116 $852
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
 148 $140 $345
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
 145 $122 $265
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
 42 $36 $175
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
 14 $74 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,732
Total received (2019-2024)
Avg $2,122/year across 6 years
Top 14% in CA for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
51
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,243 (80.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,489 (19.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,779
2023
$3,211
2022
$978
2021
$525
2020
$123
2019
$117

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$6,225
Regeneron Healthcare Solutions, Inc.
$1,156
Amgen Inc.
$217
RxSight Inc
$114
Genentech, Inc.
$35
ABBVIE INC.
$32
Top 3 companies account for 97.7% of 2024 payments
All-time payments by company (2019-2024) ›
Genentech USA, Inc.
$9,601
Regeneron Healthcare Solutions, Inc.
$1,527
Genentech, Inc.
$237
Amgen Inc.
$217
Apellis Pharmaceuticals, Inc.
$182
Dutch Ophthalmic, USA
$149
Carl Zeiss Meditec USA, Inc.
$137
Aerie Pharmaceuticals, Inc.
$117
Allergan, Inc.
$115
RxSight Inc
$114
Bausch & Lomb Americas Inc.
$109
Johnson & Johnson Surgical Vision, Inc.
$93
Alimera Sciences, Inc.
$80
ABBVIE INC.
$32
Regeneron Pharmaceuticals, Inc.
$22
Top 3 companies account for 89.3% of all-time payments
Associated products mentioned in payments ›
ARTEVO 800 · EVA · EYLEA · EYLEA HD · ILUVIEN · Lucentis · OZURDEX · RXSIGHT CONTACT LENS · Rhopressa · STELLARIS · SUSVIMO · Syfovre · TEPEZZA · Tecnis IOL · VABYSMO · Vabysmo · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a retina specialist physician in San Francisco?
Compare retina specialist physicians in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
12
Per 100K population
1.4
County median income
$141,446
Nearest hospital
CALIFORNIA PACIFIC MEDICAL CENTER- VAN NESS CAMPUS
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pasricha is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 14% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pasricha experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Pasricha performed 1,740 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pasricha receive payments from pharmaceutical companies?
Yes. Dr. Pasricha received a total of $12,732 from 15 companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pasricha's costs compare to other retina specialist physicians in San Francisco?
Dr. Pasricha's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pasricha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Retina Specialist Physicians in San Francisco
Browse retina specialist physicians in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Retina Specialist Physicians in CA
Retina specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Retina Specialist Physicians in CA
Which CA retina specialist physicians receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Genentech, Inc. Payments to Doctors
See all physicians who received payments from Genentech, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →